The European Commission has been urged to stick to its guns on the status of CBD by trade groups representing hundreds of businesses across the continent.
Benjamin-Alexandre Jeanroy, of Augur Associates, a Paris-based cannabis consultancy, believes there is ‘very little chance that the INCB’s preferred road will be taken’, as its position contradicts international law.
“If however, the EC persists on this road, we can expect another couple of years of regulatory limbo and a long and expensive process, as in the KanaVape case.”
He also believes the INCB’s Cannabis Initiative is an attempt to make itself relevant saying : “Let’s not forget that the INCB is a dying institution in constant search of legitimacy."
コメント